Skip to main content
Responses to parliamentary questions

Question from Deputy Ken O'Flynn - PQ 13632-26

Deputy O'Flynn asked about the total expenditure incurred in 2024 and 2025 on salbutamol nebules and equivalent substitute product. Read the HSE response.


Documents

Summary

To ask the Minister for Health the total expenditure incurred in 2024 and 2025 on salbutamol nebules and equivalent substitute products under the Community Drug Schemes; the additional expenditure, if any, arising from the use of Exempt Medicinal Products during shortage periods; and the budgetary provisions in place to manage future supply disruptions.


This is a beta version - your feedback will help us to improve it